Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a newer revision of the study record page. It appears to be a metadata update rather than a change to study content or outcomes.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows a new revision tag, indicating a software release version has been updated from v3.6.4 to v3.6.5. This is a metadata update and does not change the study information presented on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor backend/template update. There is no indication of changes to study details or other user-facing content.SummaryDifference0.0%

- Check77 days agoChange DetectedThe revision tag on the page has been updated from v3.6.2 to v3.6.3, signaling a new release of the site’s content or code. It reflects a metadata update rather than a substantive change to the study details or user-facing information.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, signaling a newer release of the site's underlying platform. This appears to reflect a backend/UI update rather than a change to the study information displayed.SummaryDifference0.0%

- Check98 days agoChange DetectedNew navigation and guidance sections were added to help readers understand and join the study, including 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The page also shows an updated revision label (v3.6.0) and a formatting adjustment from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.3%

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.